{"rows":[{"id":5928,"title":"Implications of Potential US FDA Approval of Psychedelics or Psychedelic-Adjacents Such as Ibogaine for Pharmacy in Japan.","authors":"Raffa RB.","journal":"Cureus","publication_date":"2026-09-13","publication_year":2026,"doi":"10.7759/cureus.116178","pubmed_id":"42733721","openalex_id":"https://openalex.org/W7212432134","source_url":"https://doi.org/10.7759/cureus.116178","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Mechanism of Action,Review Article,Treatment-Resistant Depression,Drug Interactions,Genomics","study_type":"Review Article","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-15 01:20:05","last_checked":"2026-09-20 01:20:21","bibtex":null,"source_record_id":"PMID:42733721","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.7759/cureus.116178","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42733721","source_url":"https://doi.org/10.7759/cureus.116178","doi":"10.7759/cureus.116178","pmid":"42733721","publication_date":"2026-09-13","importer_version":"2.1.3","text_redistributed":false}},{"id":3998,"title":"Acute Hallucinogen Intoxication Following Ingestion of a Commercially Available Mushroom Extract Product: A Case Report.","authors":"Udoro AJ, Yukyi Y, Ansari AZ, Gandara HA, Ahmed F, Hunt D","journal":"Cureus","publication_date":"2026-06-01","publication_year":2026,"doi":"10.7759/cureus.110791","pubmed_id":"42445624","openalex_id":"https://openalex.org/W7164736485","source_url":"https://pubmed.ncbi.nlm.nih.gov/42445624/","substance_tags":"psilocybin","topic_tags":"Anxiety,Mechanism of Action,Receptor Pharmacology,Case Report,Healthcare Workers,Toxicity","study_type":"Case Report","source_name":"PubMed","publication_status":"published","date_added":"2026-07-04 06:34:35","last_checked":"2026-08-09 08:27:47","bibtex":null,"source_record_id":"PMID:42445624","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42445624/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42445624","source_url":"https://pubmed.ncbi.nlm.nih.gov/42445624/","doi":"10.7759/cureus.110791","pmid":"42445624","publication_date":"2026-06-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2189,"title":"A Rare Presentation of Anticholinergic Toxicity in a Young Patient Due to Over-The-Counter Cold Medicines.","authors":"Khan A, Singh G, Jacob J","journal":"Cureus","publication_date":"2021-03-16","publication_year":2021,"doi":"10.7759/cureus.13919","pubmed_id":"33880270","openalex_id":"https://openalex.org/W3137989440","source_url":"https://pubmed.ncbi.nlm.nih.gov/33880270/","substance_tags":"psilocybin","topic_tags":"Older Adults,Toxicity","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:23","bibtex":null,"source_record_id":"PMID:33880270","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/33880270/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:33880270","source_url":"https://pubmed.ncbi.nlm.nih.gov/33880270/","doi":"10.7759/cureus.13919","pmid":"33880270","publication_date":"2021-03-16","importer_version":"2.1.3","text_redistributed":false}},{"id":1825,"title":"Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review.","authors":"Ziff S, Stern B, Lewis G, Majeed M, Gorantla VR","journal":"Cureus","publication_date":"2022-02-01","publication_year":2022,"doi":"10.7759/cureus.21944","pubmed_id":"35273885","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/35273885/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Addiction,End-of-Life Distress,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Safety,Toxicity","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:21","bibtex":null,"source_record_id":"PMID:35273885","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/35273885/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:35273885","source_url":"https://pubmed.ncbi.nlm.nih.gov/35273885/","doi":"10.7759/cureus.21944","pmid":"35273885","publication_date":"2022-02-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1781,"title":"Psychoactive Drugs in the Management of Post Traumatic Stress Disorder: A Promising New Horizon.","authors":"Elsouri KN, Kalhori S, Colunge D, Grabarczyk G, Hanna G, Carrasco C, Aleman Espino A, Francisco A, Borosky B, Bekheit B, Ighanifard M, Astudillo AA, Demory Beckler M","journal":"Cureus","publication_date":"2022-05-01","publication_year":2022,"doi":"10.7759/cureus.25235","pubmed_id":"35747039","openalex_id":"https://openalex.org/W4281293006","source_url":"https://pubmed.ncbi.nlm.nih.gov/35747039/","substance_tags":"psilocybin","topic_tags":"Anxiety,PTSD,End-of-Life Distress,Pharmacology,Mechanism of Action","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:20","bibtex":null,"source_record_id":"PMID:35747039","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/35747039/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:35747039","source_url":"https://pubmed.ncbi.nlm.nih.gov/35747039/","doi":"10.7759/cureus.25235","pmid":"35747039","publication_date":"2022-05-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1780,"title":"Unraveling the Mysteries of Mental Illness With Psilocybin.","authors":"Sotille R, Singh H, Weisman A, Vida T","journal":"Cureus","publication_date":"2022-05-01","publication_year":2022,"doi":"10.7759/cureus.25414","pubmed_id":"35769681","openalex_id":"https://openalex.org/W4281664591","source_url":"https://pubmed.ncbi.nlm.nih.gov/35769681/","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Neuroplasticity,Receptor Pharmacology,Clinical Trial,Review Article,Animal Study,Treatment-Resistant Depression","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:20","bibtex":null,"source_record_id":"PMID:35769681","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/35769681/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:35769681","source_url":"https://pubmed.ncbi.nlm.nih.gov/35769681/","doi":"10.7759/cureus.25414","pmid":"35769681","publication_date":"2022-05-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1753,"title":"3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review.","authors":"Inouye A, Wolfgang A","journal":"Cureus","publication_date":"2022-06-01","publication_year":2022,"doi":"10.7759/cureus.26402","pubmed_id":"35915689","openalex_id":"https://openalex.org/W4283698346","source_url":"https://pubmed.ncbi.nlm.nih.gov/35915689/","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Clinical Trial,Review Article,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:20","bibtex":null,"source_record_id":"PMID:35915689","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/35915689/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:35915689","source_url":"https://pubmed.ncbi.nlm.nih.gov/35915689/","doi":"10.7759/cureus.26402","pmid":"35915689","publication_date":"2022-06-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1694,"title":"The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry.","authors":"Kurtz JS, Patel NA, Gendreau JL, Yang C, Brown N, Bui N, Picton B, Harris M, Hatter M, Beyer R, Sahyouni R, Diaz-Aguilar LD, Castellanos J, Schuster N, Abraham ME","journal":"Cureus","publication_date":"2022-09-01","publication_year":2022,"doi":"10.7759/cureus.29167","pubmed_id":"36259015","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/36259015/","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Addiction,Receptor Pharmacology,Clinical Trial","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:19","bibtex":null,"source_record_id":"PMID:36259015","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/36259015/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:36259015","source_url":"https://pubmed.ncbi.nlm.nih.gov/36259015/","doi":"10.7759/cureus.29167","pmid":"36259015","publication_date":"2022-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1660,"title":"Potential Therapeutic Effects of Psilocybin: A Systematic Review.","authors":"Goel DB, Zilate S","journal":"Cureus","publication_date":"2022-10-01","publication_year":2022,"doi":"10.7759/cureus.30214","pubmed_id":"36381758","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/36381758/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Addiction,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Spirituality,Systematic Review,Review Article,Cancer Patients,Treatment-Resistant Depression,Contraindications","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:18","bibtex":null,"source_record_id":"PMID:36381758","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/36381758/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:36381758","source_url":"https://pubmed.ncbi.nlm.nih.gov/36381758/","doi":"10.7759/cureus.30214","pmid":"36381758","publication_date":"2022-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1655,"title":"The Efficacy of Psychedelic-Assisted Therapy in Managing Post-traumatic Stress Disorder (PTSD): A New Frontier?","authors":"Mohamed A, Touheed S, Ahmed M, Hor M, Fatima S","journal":"Cureus","publication_date":"2022-10-01","publication_year":2022,"doi":"10.7759/cureus.30919","pubmed_id":"36465766","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/36465766/","substance_tags":"psilocybin","topic_tags":"PTSD,Aging,Review Article","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:18","bibtex":null,"source_record_id":"PMID:36465766","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/36465766/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:36465766","source_url":"https://pubmed.ncbi.nlm.nih.gov/36465766/","doi":"10.7759/cureus.30919","pmid":"36465766","publication_date":"2022-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1635,"title":"Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis.","authors":"Irizarry R, Winczura A, Dimassi O, Dhillon N, Minhas A, Larice J","journal":"Cureus","publication_date":"2022-11-01","publication_year":2022,"doi":"10.7759/cureus.31796","pubmed_id":"36569662","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/36569662/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,OCD,Microdosing,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:18","bibtex":null,"source_record_id":"PMID:36569662","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/36569662/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:36569662","source_url":"https://pubmed.ncbi.nlm.nih.gov/36569662/","doi":"10.7759/cureus.31796","pmid":"36569662","publication_date":"2022-11-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1503,"title":"Predictors of Medical Students' Perceptions of Psilocybin-Assisted Therapy for Use in Medical Practice.","authors":"Wang K, Sun Y, Nava B, Sampiere L, Jacobs RJ","journal":"Cureus","publication_date":"2023-04-01","publication_year":2023,"doi":"10.7759/cureus.37450","pubmed_id":"37181969","openalex_id":"https://openalex.org/W4364356083","source_url":"https://pubmed.ncbi.nlm.nih.gov/37181969/","substance_tags":"psilocybin","topic_tags":"Addiction,End-of-Life Distress,Observational Study","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:16","bibtex":null,"source_record_id":"PMID:37181969","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/37181969/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:37181969","source_url":"https://pubmed.ncbi.nlm.nih.gov/37181969/","doi":"10.7759/cureus.37450","pmid":"37181969","publication_date":"2023-04-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1490,"title":"Cardiac Arrest Associated With Psilocybin Use and Hereditary Hemochromatosis.","authors":"Bae S, Vaysblat M, Bae E, Dejanovic I, Pierce M","journal":"Cureus","publication_date":"2023-05-01","publication_year":2023,"doi":"10.7759/cureus.38669","pubmed_id":"37288212","openalex_id":"https://openalex.org/W4372405576","source_url":"https://pubmed.ncbi.nlm.nih.gov/37288212/","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Aging,Adolescents,Adverse Events","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:16","bibtex":null,"source_record_id":"PMID:37288212","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/37288212/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:37288212","source_url":"https://pubmed.ncbi.nlm.nih.gov/37288212/","doi":"10.7759/cureus.38669","pmid":"37288212","publication_date":"2023-05-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1377,"title":"Predictors of Pharmacy Students' Attitudes About the Therapeutic Use of Psilocybin.","authors":"Bhuiya NMA, Jacobs RJ, Wang K, Sun Y, Nava B, Sampiere L, Yerubandi A, Caballero J","journal":"Cureus","publication_date":"2023-09-01","publication_year":2023,"doi":"10.7759/cureus.45169","pubmed_id":"37842360","openalex_id":"https://openalex.org/W4386702998","source_url":"https://pubmed.ncbi.nlm.nih.gov/37842360/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,OCD,End-of-Life Distress,Review Article,Observational Study,Safety","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:12","bibtex":null,"source_record_id":"PMID:37842360","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/37842360/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:37842360","source_url":"https://pubmed.ncbi.nlm.nih.gov/37842360/","doi":"10.7759/cureus.45169","pmid":"37842360","publication_date":"2023-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1334,"title":"Psychedelic Drugs or Hallucinogens: Exploring Their Medicinal Potential.","authors":"Raj P, Rauniyar S, Sapkale B","journal":"Cureus","publication_date":"2023-11-01","publication_year":2023,"doi":"10.7759/cureus.48719","pubmed_id":"38094517","openalex_id":"https://openalex.org/W4388636814","source_url":"https://pubmed.ncbi.nlm.nih.gov/38094517/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Neuroplasticity,Receptor Pharmacology,Consciousness,Aging","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:12","bibtex":null,"source_record_id":"PMID:38094517","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38094517/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38094517","source_url":"https://pubmed.ncbi.nlm.nih.gov/38094517/","doi":"10.7759/cureus.48719","pmid":"38094517","publication_date":"2023-11-01","importer_version":"2.1.3","text_redistributed":false}},{"id":848,"title":"Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.","authors":"O'Connor S, Godfrey K, Reed S, Peill J, Rohani-Shukla C, Healy M, Robbins T, Frota Lisboa Pereira de Souza A, Tyacke R, Papasyrou M, Stenbæk D, Castro-Rodrigues P, Chiera M, Lee H, Martell J, Carhart-Harris R, Pellegrini L, Fineberg NA, Nutt D, Erritzoe D","journal":"Cureus","publication_date":"2025-01-01","publication_year":2025,"doi":"10.7759/cureus.78171","pubmed_id":"39882198","openalex_id":"https://openalex.org/W4406932478","source_url":"https://pubmed.ncbi.nlm.nih.gov/39882198/","substance_tags":"psilocybin","topic_tags":"OCD,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Wellbeing,Emotional Processing,Randomized Controlled Trial","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:03","bibtex":null,"source_record_id":"PMID:39882198","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39882198/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39882198","source_url":"https://pubmed.ncbi.nlm.nih.gov/39882198/","doi":"10.7759/cureus.78171","pmid":"39882198","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":845,"title":"Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.","authors":"O'Connor S, Godfrey K, Reed S, Peill J, Rohani-Shukla C, Healy M, Robbins T, Frota Lisboa Pereira de Souza A, Tyacke R, Papasyrou M, Stenbæk D, Castro-Rodrigues P, Chiera M, Lee H, Martell J, Carhart-Harris R, Pellegrini L, Fineberg NA, Nutt D, Erritzoe D","journal":"Cureus","publication_date":"2025-01-01","publication_year":2025,"doi":"10.7759/cureus.c209","pubmed_id":"39897296","openalex_id":"https://openalex.org/W4407008238","source_url":"https://pubmed.ncbi.nlm.nih.gov/39897296/","substance_tags":"psilocybin","topic_tags":"OCD,Receptor Pharmacology","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:03","bibtex":null,"source_record_id":"PMID:39897296","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39897296/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39897296","source_url":"https://pubmed.ncbi.nlm.nih.gov/39897296/","doi":"10.7759/cureus.c209","pmid":"39897296","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":778,"title":"A Modern Overview of the Potential Therapeutic Effects of Psilocybin in the Treatment of Depressive Disorders, Treatment-Resistant Depression, and End-of-Life Distress.","authors":"Dino F","journal":"Cureus","publication_date":"2025-03-01","publication_year":2025,"doi":"10.7759/cureus.80707","pubmed_id":"40242672","openalex_id":"https://openalex.org/W4408529433","source_url":"https://pubmed.ncbi.nlm.nih.gov/40242672/","substance_tags":"psilocybin","topic_tags":"Depression,End-of-Life Distress,Pharmacology,Review Article,Treatment-Resistant Depression,Safety,Drug Interactions,Contraindications","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:01","bibtex":null,"source_record_id":"PMID:40242672","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40242672/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40242672","source_url":"https://pubmed.ncbi.nlm.nih.gov/40242672/","doi":"10.7759/cureus.80707","pmid":"40242672","publication_date":"2025-03-01","importer_version":"2.1.3","text_redistributed":false}},{"id":737,"title":"Comparative Efficacy and Functional Outcomes of Psychedelic-Assisted Therapies in Treatment-Resistant Depression: A Systematic Review of Recent Clinical Trials.","authors":"Mimms C, Sotelo K, Khaliq AS","journal":"Cureus","publication_date":"2025-04-01","publication_year":2025,"doi":"10.7759/cureus.82532","pubmed_id":"40385821","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40385821/","substance_tags":"psilocybin","topic_tags":"Depression,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study,Treatment-Resistant Depression,Safety","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:00","bibtex":null,"source_record_id":"PMID:40385821","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40385821/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40385821","source_url":"https://pubmed.ncbi.nlm.nih.gov/40385821/","doi":"10.7759/cureus.82532","pmid":"40385821","publication_date":"2025-04-01","importer_version":"2.1.3","text_redistributed":false}},{"id":649,"title":"The Clinical Applications of Psilocybin Therapies and Post-COVID Syndrome: A Comprehensive Narrative Review.","authors":"Mathew A, Dongre R, Kim SH, Turner J, Mathew A, Cherryholmes E, Mehrinfar M, Kamprath S","journal":"Cureus","publication_date":"2025-06-01","publication_year":2025,"doi":"10.7759/cureus.86659","pubmed_id":"40718283","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40718283/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Wellbeing,Clinical Trial,Review Article,In Vitro Study","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:58","bibtex":null,"source_record_id":"PMID:40718283","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40718283/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40718283","source_url":"https://pubmed.ncbi.nlm.nih.gov/40718283/","doi":"10.7759/cureus.86659","pmid":"40718283","publication_date":"2025-06-01","importer_version":"2.1.3","text_redistributed":false}}],"total":27,"page":1,"per_page":20,"pages":2,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Cureus","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}